ClinicalTrials.gg
Sign In

Malignant mesenchymal tumor clinical trials

The registry lists 31 studies for Malignant mesenchymal tumor across more than 10 countries. 1 are recruiting or about to start. 1 of them are mainly about Malignant mesenchymal tumor (how this is decided). Per ClinicalTrials.gov, last updated 2026-05-22.

Get an email when these change. Save the Malignant mesenchymal tumor studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
22
Status unknown
4
Terminated
2
Active, not recruiting
1
Recruiting
1
Withdrawn
1

Phase

Phase 2
14
Phase 3
10
Phase 1
5

Where

United States
15
United Kingdom
9
Netherlands
7
Belgium
6
Switzerland
6
Canada
6

Who runs them

European Organisation for Research and Treatment of Cancer - EORTC (9) · Children's Oncology Group (7) · National Cancer Institute (NCI) (4) · Societe Internationale d'Oncologie Pediatrique (2) · Memorial Sloan Kettering Cancer Center (2) · Novartis Pharmaceuticals (1) · Prof. Dr. Richard F Schlenk (1) · Herbert Irving Comprehensive Cancer Center (1)

What is being tested here

Drugs under test in Malignant mesenchymal tumor studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Doxorubicin034
Ifosfamide034
Irinotecan002
Vincristine022
Imatinib002
Trabectedin012
Carboplatin001
Immunocytokine NHS-IL12001
Cyclophosphamide011
Etoposide011

Drug classes tested here Alkylating agents 5 · Tyrosine kinase inhibitors (TKIs) 3

Coming up

0phase 3 studies under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

Of the 1 Malignant mesenchymal tumor studies recruiting now, 1 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 1
AgeWomenMen
100 (0%)0 (0%)
181 (100%)1 (100%)
301 (100%)1 (100%)
401 (100%)1 (100%)
501 (100%)1 (100%)
651 (100%)1 (100%)
751 (100%)1 (100%)
851 (100%)1 (100%)

Across all 31 studies, recruiting or not: 45% stop at 75 or younger and 35% at 65; 61% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 31 of 31. search them.